Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.5830
-0.0170 (-2.83%)
At close: Oct 14, 2026, 4:00 PM EDT
0.5946
+0.0116 (1.99%)
After-hours: Oct 14, 2026, 7:54 PM EDT
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $7.34 million as of October 14, 2026. It is the 43,124th most valuable company in the world and the 5,801st biggest in the United States. Its market cap has decreased by 14.28% in one year.
Market Cap
7.34M
Enterprise Value
-33.89M
1-Year Change
-14.28%
Global Rank
Country Rank
#5,801 United States
Category
ChartMarket Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $7.34M, a decrease of -61.23%. That is a compound annual growth rate of -19.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 7.34M | 23.05% |
| Dec 31, 2025 | 5.97M | -66.64% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 8.28M |
| CalciMedica | 8.26M |
| Moleculin Biotech | 8.02M |
| CollPlant Biotechnologies | 7.79M |
| Soligenix | 7.75M |
| Longeveron | 7.73M |
| CNS Pharmaceuticals | 7.54M |
| Azitra | 7.27M |